Literature DB >> 16635803

Progress and problems in the exploration of therapeutic targets.

Chanjuan Zheng1, Lianyi Han, Chun W Yap, Bin Xie, Yuzong Chen.   

Abstract

Drugs exert their therapeutic effect by binding and regulating the activity of a particular protein or nucleic acid target. A large number of targets have been explored for drug discovery. Continuous effort has been directed at the search for new targets and more-extensive exploration of existing targets. Knowledge of these targets facilitates the understanding of molecular mechanisms of drugs and the effort required for drug discovery and target searches. Areas of progress, current focuses of research and development and the difficulties in target exploration are reviewed. The characteristics of the currently explored targets and their correlation to the level of difficulty for target exploration are analyzed. From these characteristics, simple rules can be derived for estimating the difficulty level of target exploration. The feasibility of predicting druggable proteins by using simple rules and sequence-derived physicochemical properties is also discussed.

Mesh:

Substances:

Year:  2006        PMID: 16635803     DOI: 10.1016/j.drudis.2006.03.012

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  12 in total

Review 1.  Chemistry and biology of multicomponent reactions.

Authors:  Alexander Dömling; Wei Wang; Kan Wang
Journal:  Chem Rev       Date:  2012-03-22       Impact factor: 60.622

2.  Development of electron spin echo envelope modulation spectroscopy to probe the secondary structure of recombinant membrane proteins in a lipid bilayer.

Authors:  Rongfu Zhang; Indra D Sahu; Kaylee R Gibson; Nefertiti B Muhammad; Avnika P Bali; Raven G Comer; Lishan Liu; Andrew F Craig; Robert M Mccarrick; Carole Dabney-Smith; Charles R Sanders; Gary A Lorigan
Journal:  Protein Sci       Date:  2015-09-09       Impact factor: 6.725

3.  Quantitative systems-level determinants of human genes targeted by successful drugs.

Authors:  Lixia Yao; Andrey Rzhetsky
Journal:  Genome Res       Date:  2007-12-14       Impact factor: 9.043

Review 4.  Current understanding of TRPM7 pharmacology and drug development for stroke.

Authors:  Christine You Jin Bae; Hong-shuo Sun
Journal:  Acta Pharmacol Sin       Date:  2012-07-23       Impact factor: 6.150

Review 5.  TRPM7 in cerebral ischemia and potential target for drug development in stroke.

Authors:  Christine You-jin Bae; Hong-shuo Sun
Journal:  Acta Pharmacol Sin       Date:  2011-05-09       Impact factor: 6.150

6.  Characterizing protein domain associations by Small-molecule ligand binding.

Authors:  Qingliang Li; Tiejun Cheng; Yanli Wang; Stephen H Bryant
Journal:  J Proteome Sci Comput Biol       Date:  2012-12-03

7.  Application of fragment-based drug discovery to membrane proteins: identification of ligands of the integral membrane enzyme DsbB.

Authors:  Virginie Früh; Yunpeng Zhou; Dan Chen; Caroline Loch; Eiso Ab; Yelena N Grinkova; Herman Verheij; Stephen G Sligar; John H Bushweller; Gregg Siegal
Journal:  Chem Biol       Date:  2010-08-27

8.  Elucidation of the molecular mechanisms of a salicylhydrazide class of compounds by proteomic analysis.

Authors:  Xuefei Cao; Carmen Plasencia; Atsuko Kanzaki; Austin Yang; Terrence R Burke; Nouri Neamati
Journal:  Curr Cancer Drug Targets       Date:  2009-03       Impact factor: 3.428

9.  Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery.

Authors:  Feng Zhu; Zhe Shi; Chu Qin; Lin Tao; Xin Liu; Feng Xu; Li Zhang; Yang Song; Xianghui Liu; Jingxian Zhang; Bucong Han; Peng Zhang; Yuzong Chen
Journal:  Nucleic Acids Res       Date:  2011-09-24       Impact factor: 16.971

10.  Quantitative analysis on the characteristics of targets with FDA approved drugs.

Authors:  Meena K Sakharkar; Peng Li; Zhaowei Zhong; Kishore R Sakharkar
Journal:  Int J Biol Sci       Date:  2007-12-10       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.